Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.
VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
